An article by Frier Levitt attorneys has been cited in a recent piece by Drug Topics discussing the significant $45 million settlement between CVS Caremark and the State of Illinois. The article, titled “CVS PBM to Pay $45 Million in Rebates to State of Illinois,” highlights the ongoing scrutiny of Pharmacy Benefit Managers (PBMs) and their role in the drug supply chain.
Key Points from the Article:
- CVS Caremark and its rebate aggregator, Zinc Health Services, LLC, are required to pay $45 million to Illinois for failing to pass through manufacturer rebates over a 4-year contract period.
- This settlement is a major win for Illinois taxpayers and underscores the importance of transparency in PBM operations. This case underscores the critical need for transparency in the drug supply chain.
- The article emphasizes the need for clear and comprehensive rebate definitions to prevent PBM manipulation of manufacturer rebates.
The cited article, authored by Dae Lee and Adam Farkas, discusses the opaque pricing schemes of PBMs and the necessity for comprehensive rebate definitions (read here: https://www.frierlevitt.com/articles/plan-sponsor-alert-caremark-pays-45-million-to-illinois-based-on-inappropriate-rebate-withholdings/). This important discussion underscores our firm’s commitment to advocating for reform in the pharmaceutical industry, ensuring fair practices and accountability while shedding light on the complexities of PBM practices.
Read more about this pivotal case and our contributions here: https://www.drugtopics.com/view/cvs-pbm-to-pay-45-million-in-rebates-to-state-of-illinois
